Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern



Skelly, Donal T, Harding, Adam C, Gilbert-Jaramillo, Javier, Knight, Michael L, Longet, Stephanie, Brown, Anthony, Adele, Sandra, Adland, Emily, Brown, Helen, Chinnakannan, Senthil
et al (show 89 more authors) (2021) Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern. NATURE COMMUNICATIONS, 12 (1). 5061-.

[img] Text
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern.pdf - Published version

Download (2MB) | Preview

Abstract

The extent to which immune responses to natural infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and immunization with vaccines protect against variants of concern (VOC) is of increasing importance. Accordingly, here we analyse antibodies and T cells of a recently vaccinated, UK cohort, alongside those recovering from natural infection in early 2020. We show that neutralization of the VOC compared to a reference isolate of the original circulating lineage, B, is reduced: more profoundly against B.1.351 than for B.1.1.7, and in responses to infection or a single dose of vaccine than to a second dose of vaccine. Importantly, high magnitude T cell responses are generated after two vaccine doses, with the majority of the T cell response directed against epitopes that are conserved between the prototype isolate B and the VOC. Vaccination is required to generate high potency immune responses to protect against these and other emergent variants.

Item Type: Article
Uncontrolled Keywords: Medawar Laboratory Team, OPTIC (Oxford Protective T cell Immunology for COVID-19) Clinical Group, PITCH (Protective Immunity T cells in Health Care Worker) Study Group, C-MORE/PHOSP-C Group, T-Lymphocytes, Animals, Humans, Carrier Proteins, Antibodies, Monoclonal, Antibodies, Viral, Epitopes, Immunity, Antibodies, Neutralizing, COVID-19, Angiotensin-Converting Enzyme 2, SARS-CoV-2, COVID-19 Vaccines
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Infection, Veterinary and Ecological Sciences
Depositing User: Symplectic Admin
Date Deposited: 03 Feb 2022 11:42
Last Modified: 18 Jan 2023 21:14
DOI: 10.1038/s41467-021-25167-5
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3148112